DiaMedica Therapeutics Inc. (DMAC) Income Annual - Discounting Cash Flows
DMAC
DiaMedica Therapeutics Inc.
DMAC (NASDAQ)
Period Ending: LTM
(Last Twelve Months)
2024
12-31
2023
12-31
2022
12-31
2021
12-31
2020
12-31
2019
12-31
2018
12-31
2017
12-31
2016
12-31
2015
12-31
2014
12-31
2013
12-31
2012
12-31
2011
12-31
2010
12-31
2009
12-31
2008
12-31
2007
12-31
2006
12-31
2005
12-31
2004
12-31
Report Filing 2025-11-12 2025-03-17 2024-03-19 2023-03-28 2022-03-14 2021-03-10 2020-03-23 2019-03-19 2017-12-31 2016-12-31 2015-12-31 2014-12-31 2013-12-31 2012-12-31 2011-12-31 2010-12-31 2009-12-31 2008-12-31 2007-12-31 2006-12-31 2005-12-31 2004-12-31
Revenue 0 0 0 0 0 0 0 0.5 0 0 0 0 0 0 0 0 0 0 0.161 0.026 0.026 0.034
Cost of Revenue 0.029 0 0 0 0 0 0 0 0.004 0.002 0.004 0 0 0 0 0 0 0 0 0 0 0
Gross Profit -0.029 0 0 0 0 0 0 0.5 -0.004 -0.002 -0.004 0 0 0 0 0 0 0 0.161 0.026 0.026 0.034
Operating Expenses 33.57 26.68 21.27 14 13.65 12.7 11.59 7.26 4.51 2.48 1.3 4.83 7.43 10.11 6.71 3.84 2.4 1.69 2.47 0.813 0.229 0.637
Research & Development 24.39 19.06 13.11 7.84 8.77 8.21 7.9 4.52 3.21 1.76 0.886 3.71 3.78 5.21 2.33 0.804 1.37 1.04 1.07 0.617 0.023 0.462
Selling, General and Administrative 9.19 7.62 8.16 6.16 4.88 4.49 3.69 2.74 1.31 0.718 0.423 1.12 2.54 2.53 2.08 1.3 1 0.619 1.38 0.192 0.178 0.169
Other Operating Expenses 0 0 0 0 0 0 0 0 -0.004 -0.002 -0.004 0 1.11 2.37 2.3 1.74 0.03 0.027 0.018 0.003 0.028 0.006
Operating Income -33.6 -26.68 -21.27 -14 -13.65 -12.7 -11.59 -6.76 -4.52 -2.48 -1.31 -4.83 -7.43 -10.11 -6.71 -3.84 -2.4 -1.69 -2.31 -0.787 -0.203 -0.603
Net Non-Operating Interest 0 2.3 0 0 0 0 0 0 0 -0.047 -0.042 0.011 0.007 0.038 0.039 0 0 0 0 0 -0.008 -0.037
Interest Income 0 2.3 0 0 0 0 0 0 0 0.002 0.002 0.011 0.015 0.041 0.051 0 0 0 0 0 0 -0
Interest Expense 0 0 0 0 0 0 0 0 0 0.048 0.044 0 0.008 0.003 0.013 0 0 0 0 0 0.008 0.037
Equity & Other Income/(Expense) 1.7 -0.034 1.93 0.353 0.082 0.434 0.975 1.11 0.259 0.327 -0.078 0.048 0.009 0.016 0.062 -0.423 -0.035 -0.168 -0.003 0.787 0.018 0.07
Income Before Tax -31.9 -24.41 -19.34 -13.65 -13.56 -12.27 -10.62 -5.65 -4.26 -2.2 -1.43 -4.78 -7.41 -10.05 -6.61 -4.27 -2.44 -1.85 -2.31 0 -0.193 -0.57
Income Tax Expense 0.027 0.03 0.043 0.028 0.028 0.027 0.031 0.08 -0.009 0.022 0.012 0.042 0.008 -0.003 0.013 0.499 0.042 0.163 0.02 -0.009 0.018 0.07
Income Attributable to Non-Controlling Interest -0 0 0 0 0 0 0 0 0.009 0 0 0 -0.008 0.003 -0.013 -0.499 -0.042 -0.163 0 0.787 0 0
Net Income -31.93 -24.44 -19.38 -13.68 -13.59 -12.29 -10.65 -5.73 -4.26 -2.22 -1.44 -4.82 -7.41 -10.05 -6.61 -4.27 -2.44 -1.85 -2.33 -0.778 -0.211 -0.64
Depreciation and Amortization 0.043 0.039 0.03 0.025 0.024 0.021 0.021 0.015 0.004 0.002 0.004 0.002 1.11 2.37 2.3 1.67 0.03 0.027 0.018 0.003 0.028 0.006
EBITDA -33.56 -26.64 -21.24 -13.98 -13.62 -12.68 -11.57 -6.75 -4.51 -2.48 -1.31 -4.83 -6.32 -7.74 -4.41 -2.18 -2.37 -1.66 -2.29 -0.784 -0.175 -0.597
Earnings Per Share (EPS) -0.71 -0.6 -0.6 -0.52 -0.65 -0.78 -0.89 -0.74 -0.72 -0.47 -0.4 -1.55 -2.71 -4.11 -2.93 -2.98 -2.54 -2.04 -2.91 -0.89 -0.24 -0.024
Diluted Earnings Per Share -0.71 -0.6 -0.6 -0.52 -0.65 -0.78 -0.89 -0.74 -0.72 -0.47 -0.4 -1.55 -2.71 -4.11 -2.93 -2.98 -2.54 -2.04 -2.91 -0.89 -0.24 -0.024
Weighted Average Shares Outstanding 49.63 40.4 32.57 26.44 20.77 15.68 11.99 7.74 5.94 4.74 3.62 3.11 2.73 2.45 2.26 1.43 0.96 0.91 0.802 0.876 0.876 27.22
Diluted Weighted Average Shares Outstanding 49.63 40.4 32.57 26.44 20.77 15.68 11.99 7.74 5.94 4.74 3.62 3.11 2.73 2.45 2.26 1.43 0.96 0.91 0.802 0.876 0.876 27.22
discounting cash flows home logo

Discounting Cash Flows

Are you finding our services helpful? Review us on trustpilot logo Trustpilot
Have a question? Contact us
Want to become our sponsor?
Check out our Affiliate Program